Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pseudomonas Aeruginosa in Cystic Fibrosis”

97 trials

Showing 20 of 97 results

Large-scale testing (Phase 3)Study completedNCT00885365
What this trial is testing

A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

Who this might be right for
Cystic Fibrosis
Chiesi Farmaceutici S.p.A. 324
Not applicableStudy completedNCT00153634
What this trial is testing

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)

Who this might be right for
Cystic FibrosisChronic Bronchitis
Seattle Children's Hospital 75
Testing effectiveness (Phase 2)Looking for participantsNCT06368804
What this trial is testing

Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis

Who this might be right for
Bronchiectasis
Centre Hospitalier Intercommunal Creteil 196
Not applicableStudy completedNCT01319253
What this trial is testing

A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
Indiana University 27
Testing effectiveness (Phase 2)UnknownNCT03669614
What this trial is testing

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

Who this might be right for
Cystic Fibrosis
Aridis Pharmaceuticals, Inc. 102
Not applicableStudy completedNCT00043225
What this trial is testing

The Role of Bacteria and Genetic Variations in Cystic Fibrosis

Who this might be right for
Psuedomas InfectionCystic Fibrosis
National Heart, Lung, and Blood Institute (NHLBI) 76
Testing effectiveness (Phase 2)Study completedNCT00633191
What this trial is testing

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis

Who this might be right for
Cystic FibrosisInfectionPseudomonas Aeruginosa
Immunsystem AB 14
Not applicableApproved For MarketingNCT00499720
What this trial is testing

Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa Airway Infection
Gilead Sciences
Testing effectiveness (Phase 2)Study completedNCT01375049
What this trial is testing

Aztreonam Lysine for Pseudomonas Infection Eradication Study

Who this might be right for
Cystic Fibrosis
Gilead Sciences 105
Testing effectiveness (Phase 2)Study completedNCT02712983
What this trial is testing

Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection

Who this might be right for
Non-cystic Fibrosis Bronchiectasis
Novartis Pharmaceuticals 107
Large-scale testing (Phase 3)Study completedNCT00112359
What this trial is testing

International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

Who this might be right for
Cystic Fibrosis
Gilead Sciences 166
Large-scale testing (Phase 3)Study completedNCT01069705
What this trial is testing

Second Open Label Extension to Bridging Study CTBM100C2303

Who this might be right for
Pulmonary InfectionsPseudomonas Aeruginosa
Novartis Pharmaceuticals 49
Large-scale testing (Phase 3)Study completedNCT01641822
What this trial is testing

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Who this might be right for
Cystic Fibrosis
Gilead Sciences 107
Not applicableStudy completedNCT01651455
What this trial is testing

Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000

Who this might be right for
Cystic Fibrosis
Chiesi Farmaceutici S.p.A. 92
Testing effectiveness (Phase 2)Study completedNCT06159725
What this trial is testing

Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

Who this might be right for
Persistent InfectionCystic Fibrosis
Clarametyx Biosciences, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT00794586
What this trial is testing

Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection

Who this might be right for
Cystic Fibrosis
Gilead Sciences 120
Not applicableStudy completedNCT02449031
What this trial is testing

Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs

Who this might be right for
Pseudomonas Aeruginosa in Cystic Fibrosis
Mylan Inc. 409
Large-scale testing (Phase 3)Study completedNCT00128492
What this trial is testing

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

Who this might be right for
Cystic Fibrosis
Gilead Sciences 274
Not applicableStudy completedNCT01375036
What this trial is testing

Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Gilead Sciences 510
Testing effectiveness (Phase 2)Study completedNCT05010577
What this trial is testing

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Who this might be right for
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis
BiomX, Inc. 43
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation